MedTrace Logo

Prospective and Retrospective Breast Cancer Database

NCT02884284 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2016-08-31

No results posted yet for this study

Summary

In order to accelerate border crossing between basic research and clinical research in breast cancer, it is necessary to easily use clinical and biological data. That is the reason why it is very important to create a clinical, biological and pathologic beast cancer database, mainly prospective but also retrospective. All data are from patients treated in Toulouse Centre.

The scientific community will easily have access to clinical and biological informations through a centralized, structured database , leading to optimize patients with breast cancer treatment.

Conditions

Interventions

OTHER

clinical biological database collection

Sponsors & Collaborators

  • Institut Claudius Regaud

    lead OTHER

Principal Investigators

  • Florence DALENC, MD · Institut claudius regaud Toulouse ONCOPOLE

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2025-01-31
Completion
2025-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02884284 on ClinicalTrials.gov